From AI to fintech to pharma, discover stocks experts say could thrive despite market volatility and global economic shifts. See what they're watching.

Nature has become more accessible at Terra Cotta Conservation Area with the opening of a new wheelchair-accessible pollinator garden, built through a partnership between Credit Valley Conservation and ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market.

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

U.S. Food and Drug Administration Commissioner Martin Makary said on Friday that Hims & Hers' Super Bowl advertisement ...

Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of ...

Novo Nordisk, the drugmaker behind Ozempic, is laying off thousands of workers as it struggles against competition from other ...

The Novo Nordisk RTO mandate could be a strategy to encourage attrition, but if community-building is the goal, additional ...

Danish Embassy and companies joined Quezon City to launch the Philippines’ first Obesity Summit with Novo Nordisk.

The FDA sent out "100 cease-and-desist letters" to brands in response to what it says is "deceptive" pharma advertising - ...

Danish pharmaceutical giant Novo Nordisk announced 9,000 redundancies on Wednesday in response to lowered growth forecasts ...